Intrauterine growth restriction perturbs nucleosome depletion at a growth hormone-responsive element in the mouse IGF-1 gene.
Intrauterine growth restriction (IUGR) is a common human pregnancy complication. IUGR offspring carry significant postnatal risk for early-onset metabolic syndrome, which is associated with persistent reduction in IGF-1 protein expression. We have previously shown that preadolescent IUGR male mice have decreased hepatic IGF-1 mRNA and circulating IGF-1 protein at postnatal day 21, the age when growth hormone (GH) normally upregulates hepatic IGF-1 expression. Here we studied nucleosome occupancy and CpG methylation at a putative growth hormone-responsive element in intron 2 (in2GHRE) of the hepatic IGF-1 gene in normal, sham-operated, and IUGR mice. Nucleosome occupancy and CpG methylation were determined in embryonic stem cells (ESCs) and in liver at postnatal days 14, 21, and 42. For CpG methylation, additional time points out to 2 yr were analyzed. We confirmed the putative mouse in2GHRE was GH-responsive, and in normal mice, a single nucleosome was displaced from the hepatic in2GHRE by postnatal day 21, which exposed two STAT5b DNA binding sites. Nucleosome displacement correlated with developmentally programmed CpG demethylation. Finally, IUGR significantly altered the nucleosome-depleted region (NDR) at the in2GHRE of IGF-1 on postnatal day 21, with either complete absence of the NDR or with a shifted NDR exposing only one of two STAT5b DNA binding sites. An NDR shift was also seen in offspring of sham-operated mothers. We conclude that prenatal insult such as IUGR or anesthesia/surgery could perturb the proper formation of a well-positioned NDR at the mouse hepatic IGF-1 in2GHRE necessary for transitioning to an open chromatin state.
Division of Neonatology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah; and robert.mcknight@hsc.utah.edu.
Robert A
http://orcid.org/0000-0002-1435-6492
RA
McKnight
Division of Neonatology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah; and.
Christian C
CC
Yost
Division of Neonatology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah; and.
Xing
X
Yu
Division of Neonatology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah; and.
Julia E
JE
Wiedmeier
Division of Neonatology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah; and.
Christopher W
CW
Callaway
Division of Neonatology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah; and.
Ashley S
AS
Brown
Division of Neonatology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
Robert H
RH
Lane
Division of Neonatology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah; and.
Camille M
CM
Fung
D000818:Animals; D019175:DNA Methylation / Q000235:genetics*; D005260:Female; D005317:Fetal Growth Retardation / Q000235:genetics*; D019382:Human Growth Hormone / Q000235:genetics; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000235:genetics*; D051379:Mice; D009707:Nucleosomes / Q000378:metabolism*; D011247:Pregnancy
D009707:Nucleosomes; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I
DNA methylation; intrauterine growth restriction; nucleosome